Sanofi reviews

low bonus payments - even top 10% do not earn much above target bonus top performers not well rewarded poor forecasting - often significantly different than actual sales nationally and company rarely if ever adjusts the goal after they realize thier error weak managed care team somewhat bureaucratic new drug pipeline looks rather empty training is rather lax - easy to pass but some sales reps find their knowledge inadequate when they enter field sales

The meetings and bonus structure. Meetings are held a minimum of 5 times a year and last at least three days and always consist of a new sales model to learn which is a twist of the old sales model but with a new name. They also consist of endless role plays focusing on product knowledge, negotiation skills, and closing skills that sound fake when practiced and do nothing to help with sellilng skills. The goals that are set to make bonus are usually too aggressive to make very good money, but just average money: about $3000 a quarter.